Evidence map›Paper›PMID 37173702›Full record

ArticleBMC complementary medicine and therapies2023

Multiform-based Baduanjin exercise prevention and treatment for idiopathic pulmonary fibrosis: study protocol for a randomized controlled trial.

Zenan Wu, Zehao Hu, Shiwen Ke, Lisha Mo, Mingliang Qiu, Guoshuang Zhu, Wei Zhu, Liangji Liu

Abstract readClinical Trial Protocol
In one paragraph

Article in BMC complementary medicine and therapies, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed, 2 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 2 syntheses or guidelines pooled it.

  1. Pooled it
  2. Pooled it
  3. Trial
  4. Article
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Zenan WuThe Clinical Medical School Jiangxi University of Traditional Chinese Medicine, Nanchang, China.
Zehao HuThe Clinical Medical School Jiangxi University of Traditional Chinese Medicine, Nanchang, China.
Shiwen KeThe Affiliated Hospital of Jiangxi University of Traditional Chinese Medicine, Nanchang, China.
Lisha MoThe Affiliated Hospital of Jiangxi University of Traditional Chinese Medicine, Nanchang, China.
Mingliang QiuThe Affiliated Hospital of Jiangxi University of Traditional Chinese Medicine, Nanchang, China.
Guoshuang ZhuThe Clinical Medical School Jiangxi University of Traditional Chinese Medicine, Nanchang, China.
Wei ZhuThe Second Clinical Medical School, Guangzhou University of Chinese Medicine, Guangzhou, Guangdong, China.
Liangji LiuThe Affiliated Hospital of Jiangxi University of Traditional Chinese Medicine, Nanchang, China. llj6505@163.com.

Funding

Clinical Study on the Treatment of COVID-19 with Traditional Chinese Medicine No.2020YBBGW0003jiangxi Clinical Medical Research Center of Lung Diseases Gan ke fa she [2019] No. 44Jiangxi Provincial Key Laboratory of Traditional Chinese Medicine Epidemic Diseases Jiangxi Traditional Chinese Medicine Science and Education Zi [2021] No. 3Jiangxi University of Chinese Medicine Science and Technology Innovation Team Development Program No.CXTD22011Natural Science Foundation of Jiangxi Province No.2019ACBL20023Natural Science Foundation of Jiangxi Province No.20212BAB216061Natural Science Foundation of Jiangxi Province No.20212BAG70038
6 · The paper itself

Abstract

introductionIn this study, we will combine the traditional Baduanjin with Yijin Jing and Wuqinxi to create an optimized Baduanjin exercise program with three different forms (vertical, sitting, and horizontal) to adapt to idiopathic pulmonary fibrosis (IPF) patients in vairous stages of the disease. The purpose of this study is to explore and compare the therapeutic effects of this multi-form Baduanjin, traditional Baduanjin, and resistance training on lung function and limb motor function in IPF patients. The goal of this study is to prove a novel optimal exercise prescription strategy of Baduanjin exercise for improving and protecting lung function in IPF patients. METHODS/

designA single-blind and randomized controlled trial is used to conduct this study, while the randomization list will be generated using a computerized random number generator and opaque sealed envelopes with group allocation will be prepared. It will be strictly followed to blind the outcome assessors. and until the experiment's conclusion, participants won't know which group they are enrolled in. Patients between the ages of 35 and 80 who have stable diseases and have not regularly practiced Baduanjin exercise in the past will be included. They are divvied up into the following five groups at random: (1) The conventional care group (control group, CG), (2) The traditional Baduanjin exercise group (TG), (3) The modified Baduanjin exercise group (IG), (4) The resistance exercise group (RG) (5) The modified Baduanjin exercise combined with resistance exercise group (IRG). Those CG participants only received the usual treatment, while TC, IG, and RG participants exercised 1 h twice a day for 3 months. MRG participants will have a 3-month intervention with 1 h of Modified Baduanjin Exercise and 1 H of Resistance Training for each day. Every week, all groups underwent will supervis one-day training, with the exception of the control group. The Pulmonary Function Testing (PFT), HRCT, and 6MWT are the main outcome variables. The St. George Respiratory Questionnaire and mMRC are used as secondary outcome measures. DISCUSSION: This study may produce a new Baduanjin exercise prescription that is user-friendly, simple to execute, more targeted, and adaptable. Because it consists of three forms, including vertical, sitting, and horizontal, it is more adaptable to the various disease stages and actual situations of IPF patients and may compensate for the shortcomings of conventional pulmonary rehabilitation and traditional Baduanjin.

trial registrationChinese Clinical Trial Registry, ChiCTR2200055559 . Registered on 12 January 2022.

Indexed as

Exercise TherapyIdiopathic Pulmonary FibrosisAdultAgedAged, 80 and overHumansMiddle AgedRandomized Controlled Trials as TopicSingle-Blind MethodBaduanjinIdiopathic pulmonary fibrosisLung functionRCT

Identifiers

PMID37173702
PMCPMC10177735

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.